167
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning – Based on the ARCTIC Study

ORCID Icon, ORCID Icon, , ORCID Icon, , , , , ORCID Icon, & ORCID Icon show all
Pages 677-688 | Published online: 16 Mar 2021

References

  • Lopez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi:10.1111/resp.12660
  • Socialstyrelsen. Dödsorsaker 2014. Sveriges officiella statistik; 2015.
  • Jansson SA, Andersson F, Borg S, Ericsson A, Jonsson E, Lundback B. Costs of COPD in Sweden according to disease severity. Chest. 2002;122(6):1994–2002. doi:10.1378/chest.122.6.1994
  • Jansson SA, Backman H, Stenling A, Lindberg A, Ronmark E, Lundback B. Health economic costs of COPD in Sweden by disease severity–has it changed during a ten years period? Respir Med. 2013;107(12):1931–1938. doi:10.1016/j.rmed.2013.07.012
  • Pavord ID, Jones PW, Burgel PR, Rabe KF. Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11 Spec Iss:21–30. doi:10.2147/COPD.S85978
  • Sundh J, Osterlund Efraimsson E, Janson C, Montgomery S, Stallberg B, Lisspers K. Management of COPD exacerbations in primary care: a clinical cohort study. Prim Care Respir J. 2013;22(4):393–399. doi:10.4104/pcrj.2013.00087
  • Stallberg B, Janson C, Johansson G, et al. Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS). Prim Care Respir J. 2014;23(1):38–45. doi:10.4104/pcrj.2013.00106
  • Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
  • Guerra B, Gaveikaite V, Bianchi C, Puhan MA. Prediction models for exacerbations in patients with COPD. Eur Respir Rev. 2017;26(143):143. doi:10.1183/16000617.0061-2016
  • Wan ES, DeMeo DL, Hersh CP, et al. Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD). Respir Med. 2011;105(4):588–594. doi:10.1016/j.rmed.2010.11.015
  • Husebo GR, Bakke PS, Aanerud M, et al. Predictors of exacerbations in chronic obstructive pulmonary disease–results from the Bergen COPD cohort study. PLoS One. 2014;9(10):e109721. doi:10.1371/journal.pone.0109721
  • Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
  • Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: impact, measurement and mechanisms. Respirology. 2015;20(8):1160–1171. doi:10.1111/resp.12642
  • Agusti A, Calverley PM, Decramer M, Stockley RA, Wedzicha JA. Prevention of exacerbations in chronic obstructive pulmonary disease: knowns and unknowns. Chronic Obstr Pulm Dis. 2014;1(2):166–184. doi:10.15326/jcopdf.1.2.2014.0134
  • Kaszuba E, Odeberg H, Rastam L, Halling A. Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study. BMC Fam Pract. 2018;19(1):178. doi:10.1186/s12875-018-0865-8
  • Westerik JA, Metting EI, van Boven JF, Tiersma W, Kocks JW, Schermer TR. Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res. 2017;18(1):31. doi:10.1186/s12931-017-0512-2
  • Stallberg B, Janson C, Larsson K, et al. Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients. NPJ Prim Care Respir Med. 2018;28(1):33. doi:10.1038/s41533-018-0101-y
  • Annavarapu S, Goldfarb S, Gelb M, Moretz C, Renda A, Kaila S. Development and validation of a predictive model to identify patients at risk of severe COPD exacerbations using administrative claims data. Int J Chron Obstruct Pulmon Dis. 2018;13:2121–2130. doi:10.2147/COPD.S155773
  • Almagro P, Soriano JB, Cabrera FJ, et al. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest. 2014;145(5):972–980. doi:10.1378/chest.13-1328
  • Bertens LC, Reitsma JB, Moons KG, et al. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:493–499. doi:10.2147/COPD.S49609
  • Moons KG, Kengne AP, Woodward M, et al. Risk prediction models: i. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98(9):683–690. doi:10.1136/heartjnl-2011-301246
  • Amalakuhan B, Kiljanek L, Parvathaneni A, Hester M, Cheriyath P, Fischman D. A prediction model for COPD readmissions: catching up, catching our breath, and improving a national problem. J Community Hosp Intern Med Perspect. 2012;2:1. doi:10.3402/jchimp.v2i1.9915
  • Brusse-Keizer M, van der Palen J, van der Valk P, Hendrix R, Kerstjens H. Clinical predictors of exacerbation frequency in chronic obstructive pulmonary disease. Clin Respir J. 2011;5(4):227–234. doi:10.1111/j.1752-699X.2010.00234.x
  • Tavakoli H, Chen W, Sin DD, FitzGerald JM, Sadatsafavi M; Canadian Respiratory Research N. Predicting Severe COPD exacerbations: developing a population surveillance approach with administrative data. Ann Am Thorac Soc. 2020. doi:10.1513/AnnalsATS.202001-070OC
  • Lisspers K, Larsson K, Johansson G, et al. Economic burden of COPD in a Swedish cohort: the ARCTIC study. Int J Chron Obstruct Pulmon Dis. 2018;13:275–285. doi:10.2147/COPD.S149633
  • Martinell M, Stalhammar J, Hallqvist J. Automated data extraction–a feasible way to construct patient registers of primary care utilization. Ups J Med Sci. 2012;117(1):52–56. doi:10.3109/03009734.2011.653015
  • Sweden S Longitudinal integration database for health insurance and labour market studies (LISA by Swedish acronym); 2004. Available from: https://www.scb.se/en/services/guidance-for-researchers-and-universities/vilka-mikrodata-finns/longitudinella-register/longitudinal-integrationdatabase-for-health-insurance-and-labourmarket-studies-lisa/. Accessed January 07, 2019.
  • Socialstyrelsen; 2017. Available from: https://www.socialstyrelsen.se/statistik-och-data/register/alla-register/. Accessed March 8, 2021.
  • University of Manitoba – Community of Health Sciences – Manitoba Center for Health Policy. Concept Descrip¬tion: charlson comorbidity index; 2019. Available from: http://mchp-appserv.cpe.umanitoba.ca/viewConcept.php?printer=Y&conceptID=1098. Accessed March 5, 2021.
  • Chen T, Guestrin C. XGBoost: a scalable tree boosting system; 2016. Available from: https://dl.acm.org/doi/pdf/10.1145/2939672.2939785. Accessed March 8, 2021.
  • Chen YJ, Narsavage GL. Factors related to chronic obstructive pulmonary disease readmission in Taiwan. West J Nurs Res. 2006;28(1):105–124. doi:10.1177/0193945905282354
  • Hoogendoorn M, Feenstra TL, Boland M, et al. Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources. Int J Chron Obstruct Pulmon Dis. 2017;12:3183–3194. doi:10.2147/COPD.S142378
  • Larsson K, Janson C, Stallberg B, et al. Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study. Int J Chron Obstruct Pulmon Dis. 2019;14:995–1008. doi:10.2147/COPD.S195382
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450. doi:10.1186/1471-2458-11-450
  • Kjeldsen SE, Stalhammar J, Hasvold P, Bodegard J, Olsson U, Russell D. Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension. J Hum Hypertens. 2010;24(4):263–273. doi:10.1038/jhh.2009.77